Utility of FDG PET and Cardiac MRI in Diagnosis and Monitoring of Immunosuppressive Treatment in Cardiac Sarcoidosis – Radiology: Cardiothoracic Imaging
Adrienne Hislop2024-03-01T11:30:29-07:00Authors: Richard A. Coulden, MBBS • Emer P. Sonnex, MPhil • Jonathan T. Abele, MD • Andrew M. Crean, MBBS, MPhil Purpose: To compare the contributions of cardiac MRI and PET in the diagnosis and management of cardiac sarcoidosis (CS), with particular reference to quantitative measures. Read the article (PDF)